Drug intelligence / Profile preview

CholesterOff

Development stage: Unknown
Lead developer: Pharmavite
Administration: Oral

Overview

CholesterOff is an herbal supplement developed by Natural Pharmacia International (NPI) as part of its Heart Health Series. It is specifically designed for the management of hypercholesterolemia. The product is currently in Phase 1 clinical development, with trials being conducted in Asia to evaluate its safety and efficacy in lowering cholesterol levels. As a botanical-based therapeutic, it is positioned within NPI's pipeline of natural products aimed at supporting cardiovascular health. It is distinct from the similarly named plant sterol product CholestOff marketed by Nature Made.

Brand names: CholesterOff

Beyond the preview

Go deeper on CholesterOff.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CholesterOff.

Explore the full profile